Inventor · disambiguated record
Seok Gu Kang
Also filed as: KANG SEOK GU
5 granted patents·3 pending applications·8 citations·filing 2016–2022
69Inventor score
Files withUNIV YONSEI IACF3KOREA ADVANCED INST SCI & TECH2IMMUNOMET THERAPEUTICS INC1INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIV1NAT CANCER CT1
Top patents by PatentIndex Score
8 records- 0186US9539238B2Pharmaceutical composition comprising a biguanide derivative as an active ingredient for preventing or treating glioblastomaIMMUNOMET THERAPEUTICS INC·Filed 2016·Granted Jan 10, 2017·5 cites·7 claims
- 0274US10646460B2Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compoundNAT CANCER CT·Filed 2019·Granted May 12, 2020·1 cites·6 claims
- 0368US10820826B2Multiple optical fusion-image based method and apparatus for diagnosing brain tumor in real-timeUNIV YONSEI IACF·Filed 2016·Granted Nov 3, 2020·2 cites·2 claims
- 0463US2025019664A1Tumor tissue model for culturing tumor tissueUNIV YONSEI IACF·Filed 2022·Application pending·0 cites
- 0562US11998543B2Pharmaceutical composition comprising aldehyde inhibitor and anticancer agent for treatment of brain cancerUNIV YONSEI IACF·Filed 2019·Granted Jun 4, 2024·0 cites·20 claims
- 0662US2023232794A1Animal model of brain tumor and manufacturing method of animal modelKOREA ADVANCED INST SCI & TECH·Filed 2022·Application pending·0 cites
- 0755US11490603B2Animal model of brain tumor and manufacturing method of animal modelKOREA ADVANCED INST SCI & TECH·Filed 2018·Granted Nov 8, 2022·0 cites·4 claims
- 0834US2018015056A1Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compoundINDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIV·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seok Gu Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →